InvestorsHub Logo
Followers 32
Posts 5818
Boards Moderated 0
Alias Born 05/23/2006

Re: None

Friday, 06/14/2019 7:39:39 AM

Friday, June 14, 2019 7:39:39 AM

Post# of 346046
art on darzalex... sc version will drive sales...

https://www.fiercebiotech.com/biotech/j-j-bags-150m-option-genmab-s-darzalex-successor

Anti-CD38 antibody Darzalex is one of the most successful new drugs of recent years, racking up $2 billion in sales last year. Genmab expects sales to hit $3 billion this year, and analysts at Jefferies think $10 billion is achievable in the long term. The sales targets reflect the potential for Darzalex to treat patients across the multiple myeloma pathway, particularly when a subcutaneous version is available.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News